Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Interpretation of IgG subclass values: A comparison of two assays
The Journal of Pediatrics, Volume 117, No. 5, Year 1990
Notification
URL copied to clipboard!
Description
Because we have noted discordant results in the measurement of IgG subclass concentrations by means of a widely available commerclai radial immunodiffusion (RID) kit in comparison with an enzyme-linked immunosorbent assay (ELISA) developed at the Centers for Disease Control (CDC), we conducted in a blinded manner a comparison of the two assays, using sera from 48 healthy children. The correlation coefficients between the assays were 0.92, 0.82, 0.93, and 0.86 for the IgG1, IgG2, IgG3, and IgG4 assays, respectively. However, the RID assay assigned lower values for IgG1 and IgG4 determinations than the ELISA did. Furthermore, the "normal lower range values" provided by the RID assay were higher for each IgG subclass. When the sera from the healthy control subjects were analyzed with the RID assay, 12 (25%) of 48 subjects had values below the normal range for at least one subclass measurement. In contrast, with the CDC ELISA, all values were within the 95% confidence limits determined for the CDC ELISA. We suggest that age-specific normal limits be established with the use of sera from many healthy subjects for any assay measuring IgG subclass concentrations. As new groups of immunodeficiencies are defined and potential therapies are advocated, careful attention to assay standardization will result in a clearer delineation of these disease groups and of their response to treatment. © 1990 Mosby-Year Book, Inc.
Authors & Co-Authors
Broome, Claire V.
United States, Boston
Tufts Medical Center
United States, Atlanta
Centers for Disease Control and Prevention
United States, Boston
Dana-farber Cancer Institute
Rabson, Arthur R.
United States, Boston
Tufts Medical Center
United States, Atlanta
Centers for Disease Control and Prevention
United States, Boston
Dana-farber Cancer Institute
Siber, George R.
United States, Boston
Tufts Medical Center
United States, Atlanta
Centers for Disease Control and Prevention
United States, Boston
Dana-farber Cancer Institute
Connors, Mark
United States, Boston
Tufts Medical Center
United States, Atlanta
Centers for Disease Control and Prevention
United States, Boston
Dana-farber Cancer Institute
Ambrosino, Donna M.
United States, Boston
Tufts Medical Center
United States, Atlanta
Centers for Disease Control and Prevention
United States, Boston
Dana-farber Cancer Institute
Statistics
Citations: 18
Authors: 5
Affiliations: 3
Identifiers
Doi:
10.1016/S0022-3476(05)83328-1
ISSN:
00223476
Research Areas
Maternal And Child Health